DocGo (DCGO) ROCE % : 19.78% (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is DocGo ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. DocGo's annualized ROCE % for the quarter that ended in Mar. 2024 was 19.78%.

DocGo ROCE % Historical Data

The historical data trend for DocGo's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DocGo ROCE % Chart

DocGo Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

-22.76

-17.58

12.52

8.01

4.91

DocGo Quarterly Data
	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial												-9.33	2.11	11.51	14.89	19.78

DocGo ROCE % Calculation

DocGo's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	15.055	/	( ( (393.278 - 100.158)	+	(490.452 - 170.119) )	/ 2 )
	=	15.055	/	( (293.12	+	320.333)	/ 2 )
	=	15.055	/	306.7265
	=	4.91 %

DocGo's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	64.364	/	( ( (490.452 - 170.119)	+	(490.685 - 160.136) )	/ 2 )
	=	64.364	/	( ( 320.333	+	330.549 )	/ 2 )
	=	64.364	/	325.441
	=	19.78 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

DocGo (NAS:DCGO) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

DocGo ROCE % Related Terms

Thank you for viewing the detailed overview of DocGo's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

DocGo (DCGO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DocGo Inc (NAS:DCGO) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 West 35th Street, Floor 6, New York, NY, USA, 10001

Website

https://www.docgo.com

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. DocGo is disrupting the traditional four-wall healthcare system by providing care at the scale of humanity. Its technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace.

Executives

Stephen Sugrue	officer: Chief Compliance Officer	35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Lee Bienstock	officer: Chief Operating Officer	35 WEST 35TH STREET, FLOOR 6, NEW YORK NY 10001
Ely D Tendler	director, officer: General Counsel, Secretary	STRATEGIC AND LEGAL SERVICES, PLLC, 54 LAWRENCE AVENUE, LAWRENCE NY 11559
Anthony Capone	officer: President	106 DUANE ST., #3, NEW YORK NY 10007
Adriaan Stephanus Oberholzer	officer: Chief Financial Officer	35 W 35TH STREET, 6TH FLOOR, NEW YORK NY 10001
James M Travers	director	C/O FLEETMATICS, 1100 WINTER STREET, 4TH FL, WALTHAM MA 02451
Etalvina Leite	director	5477 VIA NICOLA, NEWBURY PARK CA 91320
Michael J Burdiek	director	39 PARKER, IRVINE CA 92618
Ira Smedra	director	401 N. JUNE STREET, LOS ANGELES CA 90004
Mark Do Merlin	officer: CMO, Ambulnz Holdings, LLC	35 W 35TH STREET, NEW YORK NY 10001
Michael S. Witkowski	officer: Chief Compliance Officer	PO BOX 10482, NEWBURGH NY 12552
Christopher Fillo	director	3110 MAIN STREET, SUITE 310, SANTA MONICA CA 90405
Norman Rosenberg	officer: CFO, Ambulnz Holdings, LLC	51 MOUNTAIN AVENUE, MONSEY NY 10952
Stanley Vashovsky	director, 10 percent owner, officer: Chief Executive Officer	763 RALEIGH STREET, WOODMERE NY 11598
Steven Katz	director	20 REBEL RUN DR, EAST BRUNSWICK NJ 08816